Staff Profile

Home
Staff Profile

Staff Profile List

My Statistics ASU Awards Nominated Awards Scientifc Research Scientific Achievements Workshops Conferences Education Career Progression

staff-picture

Dr. Amal Kamal Said Abdel Aziz Saad El Din

Faculty: Faculty of Pharmacy
Department: Department of Pharmacology and Toxicology
General Specialization : Pharmacology
Specialization: Cancer treatments
Degree: Associate Professor
Current Status: In Working
Official Email: AmalAbdel-Aziz@pharma.asu.edu.eg
Google Scholar: Google Scholar Link
Research Gate: Research Gate Link

Scopus: Scopus Link
H-index: N/A
Orcid: https://orcid.org/0000-0003-1709-1183
Research Fields: N/A
CV: Download CV

My Statistics

Scientifc Research

31

Citations

10156

Awards

0

Research Citations Chart

Education

No Education Was Added

Career Progression

No Career Progress Was Found

Workshops

No Workshop Was Added

Conferences

No Conference Was Added

ASU Awards

No Prizes Were Found

Scientifc Research (31)

Research Title	Year	Citations
Mechanistic approach of the inhibitory effect of chrysin on inflammatory and apoptotic events implicated in radiation-induced premature ovarian failure: emphasis on TGF-β/MAPKs …	2019	34
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain	2019	63
From Resistance to Sensitivity: Insights and Implications of Biphasic Modulation of Autophagy by Sunitinib (vol 8, 718, 2017)	2018
Comparative study of anti-VEGF Ranibizumab and Interleukin-6 receptor antagonist Tocilizumab in Adjuvant-induced Arthritis	2018	20
Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study	2018	28
Surmounting the resistance against EGFR inhibitors through the development of thieno [2, 3-d] pyrimidine-based dual EGFR/HER2 inhibitors	2018	42
Astaxanthin ameliorates doxorubicin-induced cognitive impairment (chemobrain) in experimental rat model: impact on oxidative, inflammatory, and apoptotic machineries	2018	110
From resistance to sensitivity: insights and implications of biphasic modulation of autophagy by sunitinib	2017	19
Dual modulation of MCL-1 and mTOR determines the response to sunitinib	2017	44
The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries	2016	42
Discovery of potent VEGFR-2 inhibitors based on furopyrimidine and thienopyrimidne scaffolds as cancer targeting agents	2016	114
Modulation of imatinib cytotoxicity by selenite in HCT 116 colorectal cancer cells	2015	24
Rational design, synthesis and molecular modeling studies of novel anti-oncological alkaloids against melanoma	2015	32
Chloroquine as a promising adjuvant chemotherapy together with sunitinib	2014	14
Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner	2014	70

‹
1
2
3
›

Journal Name	Published Date	Sector	Journal Website	ISSN
Leukemia	2022-03-04	Medical	Journal Website	1476-5551
Journal of Cellular Biochemistry	2022-03-27	Medical	Journal Website	1097-4644
Bioorganic Chemistry	2021-12-01	Medical	Journal Website	0045-2068
Bioorganic & Medicinal Chemistry	2022-02-15	Medical	Journal Website	0968-0896
Journal of Molecular Structure	2022-03-02	Basic Science	Journal Website	0022-2860
Biochemical Pharmacology	2022-12-01	Medical	Journal Website	0006-2952
Critical Reviews in Oncology/Hematology	2023-11-01	Medical	Journal Website	1040-8428

No Records Were Found

No Records Were Found

No Records Were Found

Nominated Awards

No Prizes Were Found

Scientific Achievements

No Scientific Achievements Were Found